PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies

Name: PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
Published: 2022
License: Public Domain

Prelude Therapeutics Incorporated · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, b-cell non-hodgkin lymphoma, chronic lymphocytic leukemia, chronic myelomonocytic leukemia, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, myelodysplastic syndromes, myeloproliferative neoplasm, small lymphocytic lymphoma, acute myeloid leukemia (aml), azacitidine

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 913895
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.